A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate Cancer

Clinical trial NCT00036543 · COMPLETED

Trial details

NCT number: NCT00036543
Sponsor: Abbott
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2001-05-01
Enrollment: 1000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.